RNS Number : 6138A
Mosman Oil and Gas Limited
24 September 2025
24 September 2025
Mosman Oil and Gas Limited
("Mosman" or the "Company")
Investor Presentation Available
Mosman Oil and Gas Limited (AIM: MSMN), the helium, hydrogen and hydrocarbon company, announces that its latest Investor Presentation (September 2025) is now available on the Company's website.
Highlights from the presentation include:
· Independent Sproule audit confirms 2U helium gross prospective resource of 134 MMscf at Sagebrush, with upside potential to 269 MMscf.
· Near-term catalysts: high-resolution 3D seismic survey commencing October 2025 and extended flow test Q4 2025-Q1 2026.
For further information, please visit: www.mosmanoilandgas.com
Enquiries:
Mosman Oil & Gas Limited Carl Dumbrell Chairman
NOMAD and Joint Broker SP Angel Corporate Finance LLP Stuart Gledhill / Richard Hail / Adam Cowl +44 (0) 20 3470 0470
Brand Communications Alan Green Tel: +44 (0) 7976 431608
Joint Broker CMC Markets UK Plc Douglas Crippen +44 (0) 020 3003 8632
Updates on the Company's activities are regularly posted on its website: www.mosmanoilandgas.com
Notes to editors
Mosman (AIM: MSMN) is a helium, hydrogen and hydrocarbon exploration, development, and production company with projects in the US and Australia. Mosman's strategic objectives remain consistent: to identify opportunities which will provide operating cash flow and have development upside, in conjunction with progressing exploration. The Company has several projects in the US, in addition to royalty interests in Australia.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NRAUSUBRVWUKURR
